Association between over- and under-replacement with thyroid hormone and incident heart failure
The Journal of Clinical Endocrinology & Metabolism · 19.05.2026 · 111 (6) · e1634-e1642
DOI: 10.1210/clinem/dgaf677 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.12.2025. Verfasst von Josh Evron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, University of North Carolina, Chapel Hill, NC 27514, USA. Hauptthemen laut MEDLINE: Heart Failure, Hormone Replacement Therapy, Thyroid Hormones, Thyroxine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Claude D. Pepper Older Americans Independence Center (OAIC), Michigan Institute for Clinical and Health Research (MICHR).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Context
Whether over- or under-replacement with thyroid hormone is associated with incident heart failure remains unclear.
Objective
Elucidate the relationship between thyroid hormone over- and under-replacement and incident heart failure.
Design
Retrospective cohort study of 641 504 adults who initiated thyroid hormone treatment between 2004 and 2017 at the Veterans Health Administration. Two cohorts of adults aged ≥18 years treated with thyroid hormone were separately studied: 638 323 adults with at least 2 outpatient thyroid stimulating hormone (TSH) measurements, and 338 249 adults with at least 2 outpatient free thyroxine (FT4) measurements, between thyroid hormone initiation and incident heart failure or study conclusion. Associations between time-varying TSH and FT4 exposure and incident heart failure as the outcome were analyzed.
Results
Overall, 564 152/641 504 (87.9%) patients were men. Median age was 66 years. Incident heart failure occurred in 81 286/641 504 (12.7%) patients. Following adjustment for age, sex, and cardiovascular risk factors (eg, smoking, hypertension), under-replacement (eg, TSH > 20 mIU/L, adjusted odds ratio [AOR], 1.93, 95% CI, 1.84-2.02; FT4 < 0.7 ng/dL, AOR 1.08; 95% CI, 1.04-1.12) and over-replacement (eg, TSH < 0.1 mIU/L, AOR, 1.06; 95% CI, 1.01-1.12; FT4 > 1.9 ng/dL, AOR, 1.23; 95% CI, 1.14-1.32) were associated with increased incident heart failure compared to euthyroidism. Incident heart failure risk was cumulative over time with both thyroid hormone over- and under-replacement, but association was strongest with under-replacement (eg, TSH > 5.5 mIU/L associated with a 5.8-fold increase in incident heart failure over 5 years).
Conclusion
Our findings suggest that thyroid hormone treatment intensity may be a modifiable risk factor for heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, University of North Carolina, Chapel Hill, NC 27514, USA.
- Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
- U.S. Department of Veterans Affairs, Center for Clinical Management Research, VA Ann Arbor, Ann Arbor, MI 48109, USA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
- Section of Cardiology, VA Ann Arbor Health System, Ann Arbor, MI 48109, USA.
- Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
ORCID-Profile: Jennifer Burns, Megan R Haymart, Maria Papaleontiou
Förderung
- NIA NIH HHS
- Claude D. Pepper Older Americans Independence Center (OAIC)
- Michigan Institute for Clinical and Health Research (MICHR)
- Michigan Biology of Cardiovascular Aging (M-BoCA)
- National Institute on Aging of the National Institutes of Health
Zitieren
APA
Evron, J., Moretti, B., Evans, R., Burns, J., Hummel, S. L., Esfandiari, N. H., Hawley, S. T., Haymart, M. R., & Papaleontiou, M. (2026). Association between over- and under-replacement with thyroid hormone and incident heart failure. The Journal of Clinical Endocrinology & Metabolism, 111(6), e1634-e1642. https://doi.org/10.1210/clinem/dgaf677
Vancouver
Evron J, Moretti B, Evans R, Burns J, Hummel SL, Esfandiari NH, et al. Association between over- and under-replacement with thyroid hormone and incident heart failure. The Journal of Clinical Endocrinology & Metabolism. 2026;111(6):e1634-e1642. doi:10.1210/clinem/dgaf677
BibTeX
@article{Evron2026,
author = {Evron, Josh and Moretti, Brandon and Evans, Richard and Burns, Jennifer and Hummel, Scott L and Esfandiari, Nazanene H and Hawley, Sarah T and Haymart, Megan R and Papaleontiou, Maria},
title = {Association between over- and under-replacement with thyroid hormone and incident heart failure},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {6},
pages = {e1634--e1642},
doi = {10.1210/clinem/dgaf677}
}
EUVIMED